Archive - Prostate Cancer Secrets

Rebuttal to “What’s the Truth About Prostate Cancer?” - 063

This newsletter is a rebuttal to an article, “What’s the Truth About Prostate Cancer,” an article framing the entire field of prostate cancer management…

Jun 10 •

Keith R. Holden, M.D.

May 2025

Multiparametric MRI for Prostate Cancer - 062

Multiparametric magnetic resonance imaging (mpMRI) is a special type of scan that combines several different imaging techniques to create detailed…

May 22 •

Keith R. Holden, M.D.

My Shocking PSA Results - 061

It had been six months since my last prostate-specific antigen (PSA) level, and I knew it was time for another set of labs.

May 5 •

Keith R. Holden, M.D.

April 2025

Liquid Biomarkers Guide Smarter Prostate Cancer Screening- 60

These blood or urine tests add detail to the PSA picture, helping to answer the question: Is this something we need to act on right now, or can we…

Apr 22 •

Keith R. Holden, M.D.

I Had Such High Hopes for Pluvicto - 059

Pluvicto is a precision type of radiation in which a radioisotope is injected into the bloodstream. The radioisotope then locates and binds to the PSMA…

Apr 7 •

Keith R. Holden, M.D.

March 2025

Using AI to Understand Prostate Cancer - 058

This newsletter is a video about how I use Google NotebookLM to research and understand prostate cancer.

Mar 24 •

Keith R. Holden, M.D.

Here's Your Gift For Being a Paid Subscriber

Mar 10 •

Keith R. Holden, M.D.

February 2025

Testosterone Replacement With A History of Prostate Cancer - 057

I chose today’s topic when I researched the guidelines for testosterone replacement therapy (TRT) in men with a history of prostate cancer and was…

Feb 20 •

Keith R. Holden, M.D.

We Want To Show You Another Miracle - 056

Approximately three weeks ago, I started having lower back pain with paresthesias down my left leg.

Feb 4 •

Keith R. Holden, M.D.

January 2025

Genetic Breakthroughs in Prostate Cancer: Unlocking the Potential of PARP Inhibitors - 055

When diagnosed with advanced prostate cancer, patients may feel their options are limited. However, breakthroughs in genetic testing and targeted…

Jan 7 •

Keith R. Holden, M.D.

December 2024

Incredible Responses to Immunotherapy - 054

Advanced prostate cancer, especially metastatic castrate-resistant prostate cancer (mCRPC), is considered incurable by prostate cancer experts.

Dec 17, 2024 •

Keith R. Holden, M.D.

November 2024

The Barriers to CAR T-Cell Therapy Success in Prostate Cancer - 053

Doctors and researchers are studying chimeric antigen receptor (CAR) T-cell therapy in advanced prostate cancer.

Nov 26, 2024 •

Keith R. Holden, M.D.

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts